Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Clinical trial NCT05773274 · RECRUITING

Trial details

NCT number: NCT05773274
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Digestive System Neuroendocrine Tumor G1 Metastatic Digestive System Neuroendocrine Tumor G2 Unresectable Digestive System Neuroendocrine Tumor G1 Unresectable Digestive System Neuroendocrine Tumor G2

Start date: 2024-01-12
Primary completion: 2029-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.